metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Acetylsalicylic acid desensitization in the new era of percutaneous coronary int...
Journal Information
Vol. 145. Issue 6.
Pages 253-257 (September 2015)
Share
Share
Download PDF
More article options
Visits
12
Vol. 145. Issue 6.
Pages 253-257 (September 2015)
Review
Acetylsalicylic acid desensitization in the new era of percutaneous coronary intervention
Desensibilización al ácido acetil salicílico en la nueva era del intervencionismo coronario percutáneo
Visits
12
Georgina Fuertes Ferre
Corresponding author
georginaff@hotmail.com

Corresponding author.
, Maria Cruz Ferrer Gracia, Isabel Calvo Cebollero
Unidad de Hemodinámica, Servicio de Cardiología, Hospital Universitario Miguel Servet, Zaragoza, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Acetylsalicylic acid desensitization protocols.
Abstract

Dual antiplatelet therapy is essential in patients undergoing percutaneous coronary intervention with stent implantation. Hypersensitivity to acetylsalicylic acid (ASA) limits treatment options. Desensitization to ASA has classically been studied in patients with respiratory tract disease. Over the last years, many protocols have been described about ASA desensitization in patients with ischaemic heart disease, including acute coronary syndrome and the need for coronary stent implantation. It is important to know the efficacy and safety of ASA desensitization in these patients.

Keywords:
Acetylsalicylic acid desensitization
Acetylsalicylic acid hypersensitivity
Ischaemic cardiomyopathy
Coronary percutaneous intervention
Resumen

El tratamiento con doble antiagregación plaquetaria es imprescindible en los pacientes que van a ser sometidos a un intervencionismo coronario percutáneo con implante de stent. La hipersensibilidad al ácido acetil salicílico (AAS) limita las posibilidades terapéuticas. La desensibilización al AAS ha sido clásicamente estudiada en pacientes con enfermedad del tracto respiratorio. En los últimos años se han descrito varios protocolos de desensibilización en pacientes con cardiopatía isquémica, incluyendo el síndrome coronario agudo y la necesidad de implante de stent coronario. Es importante conocer la eficacia y seguridad de la desensibilización al AAS en estos pacientes.

Palabras clave:
Hipersensibilidad al ácido acetil salicílico
Desensibilización al ácido acetil salicílico
Cardiopatía isquémica
Intervencionismo coronario percutáneo

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcle.2023.07.011
No mostrar más